ALZN

ALZAMEND NEURO INC

ALZN·02262M308·US·Common Stock·Healthcare - Biotechnology

ALZN (ALZAMEND NEURO INC) is held by 5 institutional investors as of Q2 2026. Largest holders: GEODE CAPITAL MANAGEMENT, LLC ($31,644), VANGUARD FIDUCIARY TRUST CO ($25,224), VANGUARD CAPITAL MANAGEMENT LLC ($9,067). Net institutional sentiment: Bearish.

5
Holders
$69,281
Total Value
20% (5)
Consensus
1 buying - 4 selling
13F: Insider & Congress: Updated regularly
ALZN

Smart Money Verdict

View all
Loading verdict
Held by 5 funds

Who's Trading

Source dates: Price Oct 13, 2026 · Insiders Aug 31, 2026 · Activists none · Congress none

InsiderAIAULT MILTON C IIISell $3KAug 26, 2026
InsiderAIAULT MILTON C IIIBuy $2KApr 14, 2026
InsiderAIAULT MILTON C IIIBuy $109KApr 14, 2026
Checking access…

Top Holders

Checking access…
Action
Decreased
26,371(-42.3%)$31,6440.0%-26.24%
0
Unchanged
21,020$25,2240.0%-30.32%
0
Increased
7,556(+71.7%)$9,0670.0%-17.92%
17
Decreased
2,352(-47.8%)$2,8220.0%-34.40%
0
Unchanged
437$5240.0%-54.83%
0
Exited
0(-100.0%)$5,5450.0%+13.21%
0
Exited
0(-100.0%)$19,0800.0%-37.50%
0
ALZNALZNALZAMEND NEURO INC

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used